☆ 4.7 Article

The Characterization of Non-oncologic Chronic Drug Therapy in Bladder Cancer Patients and the Impact on Recurrence-Free and Cancer-Specific Survival: A Prospective Study

JOURNAL OF CLINICAL MEDICINE (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Immunology

Do proton pump inhibitors alter the response to immune checkpoint inhibitors in cancer patients? A meta-analysis

Sebastien Lopes et al.

Summary: Gut microbiota can influence the effectiveness of immune checkpoint inhibitors (ICIs) in cancer patients. A meta-analysis was conducted to investigate the impact of proton pump inhibitors (PPIs) on ICIs treatment outcomes. The results suggest that concomitant use of PPIs leads to worse outcomes in terms of overall survival (OS) and progression-free survival (PFS) in advanced cancer patients treated with ICIs.

FRONTIERS IN IMMUNOLOGY (2023)

添加到收藏夹

Article Oncology

High risk of non-cancer mortality in bladder cancer patients: evidence from SEER-Medicaid

Shunde Wang et al.

Summary: The study aimed to investigate non-cancer causes of death and associated risk factors after bladder cancer diagnosis. BC patients were obtained from the SEER database and standardized mortality ratios (SMRs) were calculated using SEER*Stat software. Analysis showed that cardiovascular diseases were the leading cause of non-cancer death in BC patients, followed by respiratory diseases, diabetes mellitus, and infectious diseases. High-risk factors for non-cancer mortality included age >60 years, male gender, being white, in situ stage, transitional cell carcinoma pathological type, not receiving treatment, and widowed status.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2023)

添加到收藏夹

Article Health Care Sciences & Services

Bladder Cancer and Risk Factors: Data from a Multi-Institutional Long-Term Analysis on Cardiovascular Disease and Cancer Incidence

Biagio Barone et al.

Summary: Bladder cancer (BCa) and cardiovascular disease (CVD) have common risk factors and may share a biological pathway. A retrospective study showed a positive association between CVD and BCa incidence, with CVD being an independent protective factor for BCa. However, this effect was not confirmed for high-risk tumors.

JOURNAL OF PERSONALIZED MEDICINE (2023)

添加到收藏夹

Article Oncology

Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study

Ondrej Fiala et al.

Summary: This study found that concomitant use of proton pump inhibitors (PPI) had a negative impact on the overall survival and progression-free survival of patients with metastatic urothelial cancer (mUC) receiving pembrolizumab treatment in a real-world setting. However, the use of statins or metformin did not affect treatment response or survival.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2023)

添加到收藏夹

Article Peripheral Vascular Disease

Genetic proxies for calcium channel blockers and cancer: a Mendelian randomization study

Bohan Fan et al.

Summary: This genetic study found no association between genetic proxies for calcium channel blockers (CCBs) and 17 different types of cancer. The findings provide some support for the safety profile of CCBs in long-term use, but further replication studies are needed to provide definitive evidence.

JOURNAL OF HUMAN HYPERTENSION (2023)

添加到收藏夹

Article Oncology

Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study

Ondrej Fiala et al.

Summary: This sub-analysis of a real-world study aimed to assess the impact of concomitant use of proton pump inhibitors (PPI), statins, or metformin on the outcome of patients with metastatic urothelial cancer (mUC) receiving second-line pembrolizumab. The study found that concomitant PPI use was associated with inferior progression-free survival (PFS) and overall survival (OS), while the use of statins or metformin was not associated with response or survival.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2023)

添加到收藏夹

Article Pharmacology & Pharmacy

Retrospective evaluation of the impact of non-oncologic chronic drug therapy on the survival in patients with bladder cancer

Lisa Haimerl et al.

Summary: This study analyzed the impact of common non-oncologic chronic drug intake on survival in patients with bladder cancer and radical cystectomy. The results showed that none of the analyzed drugs had an impact on bladder cancer recurrence and survival, indicating the need for further prospective studies for more insight.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2022)

添加到收藏夹

Article Oncology

Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

T. Powles et al.

ANNALS OF ONCOLOGY (2022)

添加到收藏夹

Article Oncology

Role of Renin-Angiotensin System Blockers on BCG Response in Nonmuscle Invasive, High Risk Bladder Cancer

Giovanni Motterle et al.

Summary: The study found that the use of angiotensin receptor blockers in combination with BCG immunotherapy can improve the prognosis of patients with high-risk non muscle-invasive bladder cancer.

CLINICAL GENITOURINARY CANCER (2022)

添加到收藏夹

Review Public, Environmental & Occupational Health

The relationship between metabolic syndrome and its components with bladder cancer: a systematic review and meta-analysis of cohort studies

Mozhgan Ahmadinezhad et al.

Summary: This meta-analysis found a significant association between metabolic syndrome and bladder cancer, as well as an increased risk of bladder cancer in individuals with diabetes and hypertension. However, there was no significant relationship between obesity/overweight and bladder cancer.

EPIDEMIOLOGY AND HEALTH (2022)

添加到收藏夹

Article Oncology

Beta-blocker use and urothelial bladder cancer survival: a Swedish register-based cohort study

Ruzan Udumyan et al.

Summary: The study found that the use of beta-blockers, especially nonselective ones, was associated with lower bladder cancer-specific mortality in patients with urothelial bladder cancer. This inverse association was most pronounced in patients with locally advanced/metastatic disease.

ACTA ONCOLOGICA (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Interaction between blood pressure and genetic risk score for bladder cancer, and risk of urothelial carcinoma in men

Stanley Teleka et al.

Summary: This study found a potential additive interaction between genetic susceptibility for bladder cancer, blood pressure, and the risk of aggressive urothelial cancer in men. If replicated, these findings may provide insights for preventing aggressive urothelial cancer.

SCIENTIFIC REPORTS (2022)

添加到收藏夹

Article Geriatrics & Gerontology

Medication risks in older patients (70+) with cancer and their association with therapy-related toxicity

Imke Ortland et al.

Summary: Medication risks are common in older patients with cancer and may be associated with toxicity. This highlights the need for tailored interventions to ensure medication safety in this patient population.

BMC GERIATRICS (2022)

添加到收藏夹

Article Oncology

Long-Term Cardiovascular Mortality among 80,042 Older Patients with Bladder Cancer

Tianwang Guan et al.

Summary: This large-scale population-based study aimed to assess the causes of death, particularly cardiovascular disease (CVD) death, among older patients with bladder cancer. The study found that CVD-related death surpassed bladder cancer as the leading cause of death 5-10 years after diagnosis, especially in localized-stage and low-grade tumors. Older bladder cancer patients also had a higher risk of CVD-related death compared to the general population. The findings highlight the importance of managing not only the primary cancer but also the competing risk of CVD-related death in older patients with bladder cancer.

CANCERS (2022)

添加到收藏夹

Review Health Care Sciences & Services

Association of Hypertension and Organ-Specific Cancer: A Meta-Analysis

Morgan Connaughton et al.

Summary: Hypertension and cancer are two leading causes of death worldwide. Hypertension, when present independently, is associated with an increased risk of cancer. Studies have found a correlation between hypertension and specific organ cancers, with certain angiogenesis factors potentially playing a key role in cancer development in hypertensive patients. These findings offer new insights into the treatment and prevention of cancer in individuals with hypertension.

HEALTHCARE (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Exposure to Ranitidine and Risk of Bladder Cancer: A Nested Case-Control Study

Chris R. Cardwell et al.

Summary: In this study, the use of ranitidine was associated with an increased risk of bladder cancer, particularly with long-term use. There was little evidence of any association between proton pump inhibitor use and bladder cancer risk in this population-based study. Further research is needed to confirm these findings in other settings.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)

添加到收藏夹

Article Oncology

Association of Polypharmacy with Colorectal Cancer Survival Among Older Patients

Li-Ju Chen et al.

Summary: Polypharmacy is common in older patients with colorectal cancer, with the use of eight or more drugs being associated with a negative impact on survival. It is suggested that medication review and deprescribing of drugs without indication may benefit older patients with CRC.

ONCOLOGIST (2021)

添加到收藏夹

Article Oncology

Lipid-Lowering Drug Use and Cancer Incidence and Mortality in the ARIC Study

Michael T. Marrone et al.

Summary: This study provides additional evidence for inverse associations between lipid-lowering drug use and cancer incidence and mortality, but a positive association with bladder cancer incidence in men. The inverse associations were consistent by sex and race.

JNCI CANCER SPECTRUM (2021)

添加到收藏夹

Article Urology & Nephrology

Age above 70 years and Charlson Comorbidity Index higher than 3 are associated with reduced survival probabilities after radical cystectomy for bladder cancer. Data from a contemporary series of 334 consecutive patients

Massimo Maffezzini et al.

Summary: Both age over 70 years and a Charlson Comorbidity Index (CCI) greater than 3 were identified as significant factors restricting the survival of radical cystectomy (RC). When comparing RC outcomes, both factors should be taken into consideration.

ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA (2021)

添加到收藏夹

Review Oncology

Associations of Polypharmacy and Inappropriate Medications with Adverse Outcomes in Older Adults with Cancer: A Systematic Review and Meta-Analysis

Mostafa R. Mohamed et al.

ONCOLOGIST (2020)

添加到收藏夹

Article Oncology

Sex Differences in Urothelial Bladder Cancer Survival

Cecilia Radkiewicz et al.

CLINICAL GENITOURINARY CANCER (2020)

添加到收藏夹

Article Urology & Nephrology

Association between Development of Metabolic Acidosis and Improvement of Urinary Continence after Ileal Neobladder Creation

Guido Mueller et al.

JOURNAL OF UROLOGY (2020)

添加到收藏夹

Review Cell Biology

Antihypertensive medications are associated with the risk of kidney and bladder cancer: a systematic review and meta-analysis

Yuxiu Xie et al.

AGING-US (2020)

添加到收藏夹

Article Oncology

Bladder cancer risk in users of selected drugs for cardiovascular disease prevention

Valentina Guercio et al.

EUROPEAN JOURNAL OF CANCER PREVENTION (2019)

添加到收藏夹

Article Urology & Nephrology

Risk of urothelial cancer death among people using antihypertensive drugs-a cohort study from Finland

Eerik E. E. Santala et al.

SCANDINAVIAN JOURNAL OF UROLOGY (2019)

添加到收藏夹

Article Urology & Nephrology

Association between occurrence of urinary bladder cancer and treatment with statin medication

Erik Lundberg et al.

TURKISH JOURNAL OF UROLOGY (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

Diagnostic potential of major and trace elements in the serum of bladder cancer patients

Sven Wach et al.

JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY (2018)

添加到收藏夹

Review Chemistry, Medicinal

Bladder Cancer Chemopreventive Agents: Current Knowledge and Concepts

N. Rezakahn Khajeh et al.

MINI-REVIEWS IN MEDICINAL CHEMISTRY (2018)

添加到收藏夹

Review Oncology

Systematic Review of Comorbidity and Competing-risks Assessments for Bladder Cancer Patients

Stephen B. Williams et al.

EUROPEAN UROLOGY ONCOLOGY (2018)

添加到收藏夹

Article Oncology

Prognostic Impact of Renin-Angiotensin Inhibitors in Patients with Bladder Cancer Undergoing Radical Cystectomy

Takashi Yoshida et al.

ANNALS OF SURGICAL ONCOLOGY (2017)

添加到收藏夹

Review Geriatrics & Gerontology

What is polypharmacy? A systematic review of definitions

Nashwa Masnoon et al.

BMC GERIATRICS (2017)

添加到收藏夹

Article Oncology

Can daily intake of aspirin and/or statins influence the behavior of non-muscle invasive bladder cancer? A retrospective study on a cohort of patients undergoing transurethral bladder resection

Antonio Luigi Pastore et al.

BMC CANCER (2015)

添加到收藏夹

Article Urology & Nephrology

Renin-Angiotensin Inhibitors Decrease Recurrence after Transurethral Resection of Bladder Tumor in Patients with Nonmuscle Invasive Bladder Cancer

Michael L. Blute et al.

JOURNAL OF UROLOGY (2015)

添加到收藏夹

Article Medicine, General & Internal

Effect of Hypertension on Outcomes of High-Risk Patients After BCG-Treated Bladder Cancer A Single-Institution Long Follow-Up Cohort Study

Fabrizio Dal Moro et al.

MEDICINE (2015)

添加到收藏夹

Article Oncology

Drug-related problems in elderly patients with cancer receiving outpatient chemotherapy

Yeoh Ting Ting et al.

JOURNAL OF GERIATRIC ONCOLOGY (2015)

添加到收藏夹

Article Urology & Nephrology

Un mayor índice de comorbilidad de Charlson se relaciona con características más agresivas de los tumores vesicales de novo

L. Mateu et al.

Actas Urologicas Espanolas (2015)

添加到收藏夹

Article Oncology

Prevalence and factors associated with polypharmacy in older people with cancer

Justin P. Turner et al.

SUPPORTIVE CARE IN CANCER (2014)

添加到收藏夹

Article Public, Environmental & Occupational Health

Medication use of adults in Germany. Results of the German Health Interview and Examination Survey for Adults (DEGS1)

H. Knopf et al.

BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ (2013)

添加到收藏夹

Article Urology & Nephrology

Impact of Statin Use on Oncologic Outcomes in Patients with Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy

Rodrigo Donalisio da Silva et al.

JOURNAL OF UROLOGY (2013)

添加到收藏夹

Article Oncology

Prognostic Value of Renin-Angiotensin System Blockade in Non-muscle-invasive Bladder Cancer

Kazuyuki Yuge et al.

ANNALS OF SURGICAL ONCOLOGY (2012)

添加到收藏夹

Article Urology & Nephrology

Long-Term Use of Supplemental Vitamins and Minerals Does Not Reduce the Risk of Urothelial Cell Carcinoma of the Bladder in the VITamins And Lifestyle Study

James M. Hotaling et al.

JOURNAL OF UROLOGY (2011)

添加到收藏夹

Article Urology & Nephrology

Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials

RJ Sylvester et al.

EUROPEAN UROLOGY (2006)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.